Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Improving efficacy of diabetes management using treatment algorithms in a mainly Hispanic population.

    Fanning EL, Selwyn BJ, Larme AC, DeFronzo RA.

    Diabetes Care. 2004 Jul;27(7):1638-46.PMID: 15220240 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of nurse-directed diabetes care in a minority population.

    Davidson MB.

    Diabetes Care. 2003 Aug;26(8):2281-7.PMID: 12882849 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers.

    Mazzolini TA, Irons BK, Schell EC, Seifert CF.

    J Manag Care Pharm. 2005 Nov-Dec;11(9):763-71.PMID: 16300420 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of a pharmacist-managed diabetes care program in a free medical clinic.

    Davidson MB, Karlan VJ, Hair TL.

    Am J Med Qual. 2000 Jul-Aug;15(4):137-42.PMID: 10948785 [PubMed - indexed for MEDLINE]Related articles

    6.

    Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change.

    Grant RW, Buse JB, Meigs JB; University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team.

    Diabetes Care. 2005 Feb;28(2):337-442.PMID: 15677789 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Development and evaluation of a patient-oriented education system for diabetes management.

    Lee TI, Yeh YT, Liu CT, Chen PL.

    Int J Med Inform. 2007 Sep;76(9):655-63. Epub 2006 Jul 3.PMID: 16815741 [PubMed - indexed for MEDLINE]Related articles

    8.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.

    Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A; SFIDA Study Group--Italian Association of Diabetologists (AMD).

    Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204-11.PMID: 15955469 [PubMed - indexed for MEDLINE]Related articles

    10.

    Dosing of insulin glargine in the treatment of type 2 diabetes.

    Barnett A.

    Clin Ther. 2007 Jun;29(6):987-99. Review.PMID: 17692716 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of population management with direct physician feedback on care of patients with type 2 diabetes.

    Grant RW, Hamrick HE, Sullivan CM, Dubey AK, Chueh HC, Cagliero E, Meigs JB.

    Diabetes Care. 2003 Aug;26(8):2275-80.PMID: 12882848 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Development and clinical outcomes of pharmacist-managed diabetes care clinics.

    Morello CM, Zadvorny EB, Cording MA, Suemoto RT, Skog J, Harari A.

    Am J Health Syst Pharm. 2006 Jul 15;63(14):1325-31.PMID: 16809752 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of self-management training in Type 2 diabetes: a randomized, prospective trial.

    Kulzer B, Hermanns N, Reinecker H, Haak T.

    Diabet Med. 2007 Apr;24(4):415-23. Epub 2007 Feb 12.PMID: 17298590 [PubMed - indexed for MEDLINE]Related articles

    15.

    Diabetes self-management among low-income Spanish-speaking patients: a pilot study.

    Rosal MC, Olendzki B, Reed GW, Gumieniak O, Scavron J, Ockene I.

    Ann Behav Med. 2005 Jun;29(3):225-35.PMID: 15946117 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals.

    Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, Greene RS, Jolly JL, Nelson AA.

    J Am Pharm Assoc (2003). 2006 May-Jun;46(3):370-7. Erratum in: J Am Pharm Assoc (Wash DC). 2006 Nov-Dec;46(6):666-7. PMID: 16739759 [PubMed - indexed for MEDLINE]Related articles

    17.
    18.

    Continuity and quality of care in type 2 diabetes: a Residency Research Network of South Texas study.

    Parchman ML, Burge SK; Residency Research Network of South Texas Investigators.

    J Fam Pract. 2002 Jul;51(7):619-24.PMID: 12160500 [PubMed - indexed for MEDLINE]Related articles

    19.

    Texas-Mexico border intervention by promotores for patients with type 2 diabetes.

    Sixta CS, Ostwald S.

    Diabetes Educ. 2008 Mar-Apr;34(2):299-309.PMID: 18375779 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data